Select Medical (NYSE:SEM) Stock Price Crosses Above 200 Day Moving Average – Here’s Why

Select Medical Holdings Corporation (NYSE:SEM)’s share price crossed above its 200-day moving average during trading on Friday . The stock has a 200-day moving average of $15.70 and traded as high as $16.56. Select Medical shares last traded at $16.5350, with a volume of 465,583 shares changing hands.

Analysts Set New Price Targets

SEM has been the topic of several recent analyst reports. Royal Bank Of Canada reiterated a “sector perform” rating and set a $16.50 price objective (down from $19.00) on shares of Select Medical in a research report on Tuesday, March 3rd. Zacks Research upgraded shares of Select Medical from a “strong sell” rating to a “hold” rating in a research report on Monday, May 4th. Mizuho reiterated a “neutral” rating and set a $16.50 price objective (down from $17.00) on shares of Select Medical in a research report on Tuesday, May 12th. Wall Street Zen cut shares of Select Medical from a “buy” rating to a “hold” rating in a research report on Monday, March 9th. Finally, Benchmark cut shares of Select Medical from a “buy” rating to a “hold” rating in a research report on Wednesday, March 4th. One analyst has rated the stock with a Buy rating and six have assigned a Hold rating to the company. According to data from MarketBeat.com, the company has an average rating of “Hold” and an average target price of $15.50.

Select Medical Price Performance

The firm’s 50-day moving average is $16.44 and its two-hundred day moving average is $15.70. The company has a market cap of $2.05 billion, a P/E ratio of 15.60, a PEG ratio of 0.95 and a beta of 1.01. The company has a debt-to-equity ratio of 0.88, a current ratio of 1.15 and a quick ratio of 1.15.

Select Medical (NYSE:SEM) last announced its quarterly earnings results on Thursday, April 30th. The health services provider reported $0.36 earnings per share for the quarter, missing the consensus estimate of $0.43 by ($0.07). Select Medical had a return on equity of 6.62% and a net margin of 2.42%.The business had revenue of $1.42 billion during the quarter, compared to the consensus estimate of $1.41 billion. During the same quarter in the prior year, the firm posted $0.44 EPS. The company’s revenue for the quarter was up 5.0% on a year-over-year basis. Select Medical has set its FY 2026 guidance at 1.220-1.320 EPS. Analysts anticipate that Select Medical Holdings Corporation will post 1.26 earnings per share for the current year.

Select Medical Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Thursday, May 28th. Investors of record on Thursday, May 14th were given a $0.0625 dividend. This represents a $0.25 annualized dividend and a yield of 1.5%. The ex-dividend date was Thursday, May 14th. Select Medical’s payout ratio is currently 23.58%.

Select Medical declared that its board has approved a stock repurchase program on Thursday, February 19th that permits the company to buyback $1.00 billion in shares. This buyback authorization permits the health services provider to repurchase up to 49.5% of its shares through open market purchases. Shares buyback programs are typically a sign that the company’s leadership believes its shares are undervalued.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently bought and sold shares of the company. Alpine Woods Capital Investors LLC purchased a new position in Select Medical during the first quarter worth $295,000. Segall Bryant & Hamill LLC boosted its stake in Select Medical by 65.3% during the first quarter. Segall Bryant & Hamill LLC now owns 281,857 shares of the health services provider’s stock worth $4,566,000 after buying an additional 111,329 shares during the period. Groupe la Francaise purchased a new position in Select Medical during the first quarter worth $4,602,000. Quantinno Capital Management LP boosted its stake in Select Medical by 19.2% during the first quarter. Quantinno Capital Management LP now owns 33,469 shares of the health services provider’s stock worth $545,000 after buying an additional 5,384 shares during the period. Finally, Polar Asset Management Partners Inc. purchased a new position in Select Medical during the first quarter worth $22,806,000. 89.48% of the stock is owned by hedge funds and other institutional investors.

Select Medical Company Profile

Select Medical is a leading provider of specialized healthcare services in the United States, operating through two primary business segments: Hospital Division and Outpatient Rehabilitation Division. The Hospital Division offers long-term acute care (LTAC) hospitals and inpatient rehabilitation facilities (IRFs) that serve patients recovering from complex illnesses, trauma or surgery. The Outpatient Rehabilitation Division delivers physical, occupational and speech therapy services through a network of clinic locations and home-based care programs.

Headquartered in Mechanicsburg, Pennsylvania, Select Medical was founded in 1996 and has grown through strategic partnerships, joint ventures and acquisitions.